The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biodyn Share News (OBD)

Share Price Information for Oxford Biodyn (OBD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.90
Bid: 7.66
Ask: 7.90
Change: 0.00 (0.00%)
Spread: 0.24 (3.133%)
Open: 7.90
High: 7.90
Low: 7.90
Prev. Close: 7.90
OBD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK DIRECTOR DEALINGS SUMMARY: RHI Magnesita Chair Spends EUR8 Million

Tue, 14th Apr 2020 15:59

(Alliance News) - The follow is a round-up of share dealings by London-listed company directors and managers announced on Tuesday and Thursday last week and not separately reported by Alliance News:

----------

RHI Magnesita NV - Chair Herbert Cordt buys 350,000 shares at EUR23.64, worth EUR8.3 million, on Friday last week outside a trading venue.

----------

Circassia Pharmaceuticals PLC - Executive team buy 700,000 shares at 22.68p to 23.20p, worth about GBP160,000, on Thursday last week. Executive Chair Ian Johnson buys 200,000 shares, his only holding. Chief Financial Officer Michael Roller also buys 200,000, also his only holding. Chief Operating Officer Jonathan Emms buys 300,000 shares and now has 600,000, a 0.2% stake.

----------

Pebble Group PLC - Chair Richard Law and Chief Executive Officer Chris Lee each buy 100,000 shares and Independent Non-Executive Director Yvonne Monaghan buys 20,000 shares. All on Thursday last week at 77.5p and together worth GBP170,500. Law now holds 195,238 shares and Monaghan 35,000. Lee has 6.0 million shares, a 3.6% stake.

----------

Restaurant Group PLC - Directors including Chair Debbie Hewitt, CEO Andy Hornby and CFO Kirk Davis buy 100,000 shares at GBP0.58 in company's GBP57 million fundraise last week. Hewitt takes 30,000, Hornby 10,000 and Davis 40,000. Non-executive directors Graham Clemett and Zoe Morgan each take 10,000 shares. All on Wednesday last week.

----------

ASOS PLC - Non-Executive Director Nicholas Robertson sells 1.0 million shares at GBP21.00, worth GBP21.0 million, on Thursday last week. The shares were pledged to Credit Suisse (UK) Ltd to cover a margin loan facility and were sold to close the position with the bank. Robertson now has 3.6 million shares, a 3.6% stake, and none of these shares are subject to any pledge or security, ASOS said.

----------

Medica Group PLC - Medical Director Stephen Davies buys 58,252 shares at 103p, worth GBP60,000, on Thursday last week. Now holds 1.6 million shares, 1.4% of total. Chief Technical Officer Marc O'Brien buys 9,556 shares at 104p, worth GBP9,938, also on Thursday. Now has 10,335 shares.

----------

JD Wetherspoon PLC - James Ullman, audit director, sells 1,000 shares at GBP10.33, worth GBP10,330, on Thursday last week.

----------

Gamma Communications PLC - Non-Executive Director Andrew Stone buys 100,000 shares, at 1,150p to 1,1250p, worth GBP1.2 million, on Tuesday, Wednesday and Thursday last week. Now holds 215,551 shares.

----------

Manchester & London Investment Trust PLC - Investment Manager Mark Sheppard sells 60,000 shares at GBP5.42 and GBP5.60, worth GBP327,900, on Thursday last week.

----------

Real Estate Credit Investments Ltd - Director John Hallam buys 10,000 shares at GBP1.18, worth GBP11,800, on Thursday last week.

----------

Intercede Group PLC - CEO Klaas van der Leest buys 15,000 shares at 49.0p, worth GBP7,350, on Wednesday and Thursday last week. Now has 18,904 shares.

----------

Plus500 Ltd - Julie Winton, wife of Plus500UK CEO Mark Winton, buys 3,699 shares at GBP10.809, worth GBP39,982, on Wednesday last week.

----------

TT Electronics PLC - Non-Executive Director Warren Tucker buys 11,630 shares at GBP1.71, worth GBP19,887, on Tuesday.

----------

Pressure Technologies PLC - Chief Executive Chris Walters buys 18,000 shares at 90p, worth GBP16,200, on Tuesday. The shares are his only holding.

----------

Prudential PLC - Non-Executive Director Jeremy Anderson buys 9,157 shares at GBP10.86, worth GBP99,445, on Thursday last week.

----------

Oxford BioDynamics PLC - Non-Executive Director, Stephen Diggle buys 20,000 shares via Vulpes Testudo Fund at 52.5p, worth GBP10,500, on Wednesday and Thursday last week. Now interested in 12.1 million shares, a 13% stake.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
6 Jun 2019 15:54

DIRECTOR DEALINGS: Non-Exec Linked Fund Buys Oxford BioDynamics Shares

LONDON (Alliance News) - Oxford BioDynamics PLC said Thursday that Vulpes Life Sciences Fund, controlled by Non-Executive Director Steven Diggle, purchased around GBP12,700 in shares in a on fund

Read more
31 May 2019 13:01

Long-Serving Oxford Biodynamics Non-Executive Kibble Stands Down

LONDON (Alliance News) - Biotechnology firm Oxford Biodynamics PLC said Friday Non-Executive Director Alison Kibble has stepped down from the firm after 11 years on the board.Kibble - first

Read more
28 May 2019 11:50

Oxford BioDynamics Half Year Loss Widens On Increased Costs

LONDON (Alliance News) - Oxford BioDynamics PLC on Tuesday said its loss widened in the first half of its financial year due to higher staff and administrative costs.Shares in Oxford were a

Read more
21 May 2019 16:05

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 22 May Marks & Spencer GroupFull Year ResultsRoyal MailFull Year Year Year

Read more
3 May 2019 14:19

Oxford BioDynamics Chosen To Join ALS Biomarker Study

LONDON (Alliance News) - Oxford Biodynamics PLC said on Friday it has joined the REFINE-ALS study, designed to identify specific biomarkers in people with amyotrophic lateral sclerosis.The

Read more
23 Apr 2019 10:33

Three AIM firms celebrate Queen's Award for Enterprise wins

(Sharecast News) - Three firms trading on London's AIM market were celebrating wins in the Queen's Award for Enterprise on Tuesday, with Inspiration Healthcare, Ergomed and Oxford BioDynamics all picking up the accolades.

Read more
5 Apr 2019 11:25

Oxford BioDynamics Appoints Non-Executive Director As Interim Chair

LONDON (Alliance News) - Oxford BioDynamics PLC said on Friday it has promoted Non-Executive Director Steven Wiggle as interim chair with immediate effect.Wiggle will be replacing David who

Read more
2 Apr 2019 12:08

Oxford BioDynamics Launches US Business With New Commerical Head

LONDON (Alliance News) - Biotechnology firm Oxford BioDynamics PLC said Tuesday it has established a US subsidiary and appointed a commercial head for the country.In line with its strategy

Read more
19 Mar 2019 11:54

Oxford BioDynamics EpiSwitch Test Included In Cancer Screening Study

LONDON (Alliance News) - Oxford BioDynamics PLC on Tuesday said it has signed an agreement for its EpiSwitch test to be used by Imperial College London in a prostate cancer screening College is to

Read more
19 Mar 2019 11:43

Oxford BioDynamics biomarker to be used in prostate cancer test trial

(Sharecast News) - Oxford BioDynamics announced on Tuesday that it has signed an agreement with Imperial College London, to utilise its latest 'EpiSwitch' biomarker signature for the blood-based diagnosis of prostate cancer in the 'PROSTAGRAM' trial.

Read more
15 Feb 2019 14:55

DIRECTOR DEALINGS: Oxford BioDynamics Non-Exec's Associate Buys Shares

LONDON (Alliance News) - Oxford BioDynamics PLC on Friday said that the Vulpie Life Sciences Fund, controlled by Non-Executive Director Steven Diggle, purchased nearly GBP37,000 in stock over two

Read more
11 Jan 2019 10:21

Oxford Biodynamics Chair And Long-Serving Non-Exec To Stand Down

LONDON (Alliance News) - Biotechnology company Oxford Biodynamics PLC said Friday Chair David Williams and Non-Executive Director Alison Kibble will stand down later in 2019.Williams - 2016

Read more
11 Dec 2018 11:47

Oxford BioDynamics Annual Loss Narrows On Lower Costs

LONDON (Alliance News) - Oxford BioDynamics PLC on Tuesday reported a sharply narrowed annual loss due to absence of initial public offering related costs.For the year ended September 30, a

Read more
29 Aug 2018 17:03

GL Healthcare Holds 5% Oxford Biodynamics Stake After Deal (ALLISS)

LONDON (Alliance News) - Oxford Biodynamics PLC said Wednesday that GL Healthcare Investment LP holds a 5.1% stake in the biotechnology company after a transaction on Tuesday.GL holding the

Read more
22 Aug 2018 10:26

Chinese Investor Chooses Oxford BioDynamics As First European Partner (ALLISS)

LONDON (Alliance News) - Oxford BioDynamics PLC on Wednesday said a Chinese investment management firm has invested GBP9.8 million in the company.GL Capital Group, which focuses on firms, a

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.